|
 | Up a level |
Liang, Z and Lin, X and Sun, L and Edwards, KM and Song, W and Sun, H and Xie, Y and Lin, F and Ling, S and Liang, T and Xiao, B and Wang, J and Li, M and Leung, C-Y and Zhu, H and Bhandari, N and Varadarajan, R and Levine, MZ and Peiris, M and Webster, R and Dhanasekaran, V and Leung, NHL and Cowling, BJ and Webby, RJ and Ducatez, M and Zanin, M and Wong, S-S (2024) A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases. In: Nature Communications, 15 (1).
Jia, JZ and Cohen, CA and Gu, H and McLean, MR and Varadarajan, R and Bhandari, N and Peiris, M and Leung, GM and Poon, LLM and Tsang, T and Chung, AW and Cowling, BJ and Leung, NHL and Valkenburg, SA (2024) Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children. In: Nature Communications, 15 (1).
Panickan, S and Bhatia, S and Bhat, S and Bhandari, N and Pateriya, AK and Kalaiyarasu, S and Sood, R and Tripathi, M (2022) Reverse genetics based H5N2 vaccine provides clinical protection against H5N1, H5N8 and H9N2 avian influenza infection in chickens. In: Vaccine, 40 (48). 6998 -7008.
